A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Effectiveness of vaccines and monoclonal antibodies against respiratory syncytial virus: Generic protocol for register-based cohort study




TekijätPoukka Eero, van Roekel Caren, Turunen Topi, Baum Ulrike, Kramer Rolf, Begier Elizabeth, Presser Lance, Teirlinck Anne, Heikkinen Terho, Knol Mirjam, Nohynek Hanna; PROMISE Investigators

KustantajaOxford University Press

Julkaisuvuosi2024

JournalJournal of Infectious Diseases

Tietokannassa oleva lehden nimiThe Journal of Infectious Diseases

Vuosikerta229

NumeroSuppl. 1

AloitussivuS84

LopetussivuS91

ISSN0022-1899

eISSN1537-6613

DOIhttps://doi.org/10.1093/infdis/jiad484

Verkko-osoitehttps://doi.org/10.1093/infdis/jiad484


Tiivistelmä
Currently several immunisation products are being developed against respiratory syncytial virus (RSV) for children, pregnant females and older adults, and some products have already received authorisation. Therefore, studies to monitor the effectiveness of these products are needed in the following years. To assist researchers to conduct post-marketing studies, we developed a generic protocol for register-based cohort studies to evaluate immunisation product effectiveness against RSV-specific and non-specific outcomes. To conduct a study on the basis of this generic protocol the researchers can use any relevant databases or healthcare registers that are available at the study site.



Last updated on 2025-15-08 at 14:16